| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +1.52M | 63.1% | $33.00 | +$50M |
| Sells | 3 | -886K | 36.9% | $28.76 | -$25.5M |
| Net | -2 | +629K | 26.2% | +$24.5M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Hong Fang Song | Director | $196M | -$22.4M | -10.2% | Sep 3, 2025 |
| Decheng Capital Global Life Sciences Fund IV, L.P. | 10%+ Owner | $175M | Jan 29, 2024 | ||
| Brian Guan-Chyun Liu | Director | $50M | +$50M | Sep 11, 2025 | |
| James Mulay | Director | $0 | -$2.5M | -100% | Oct 9, 2025 |
| Leonard Post | Director | $0 | -$613K | -100% | Nov 17, 2025 |
| Corleen Roche | Cfo | Apr 15, 2025 | |||
| Arthur Kuan | Chief Executive Officer, Director | Apr 15, 2025 | |||
| Bob Lapetina | Interim Principal Financial and Accounting Officer | Aug 5, 2025 | |||
| Susan E. Graf | Director | Jun 5, 2025 | |||
| Ambaw Bellete | President and COO | Apr 15, 2025 | |||
| Victor Edward Tong Jr | Director | Jun 5, 2025 | |||
| Joshua F. Patterson | General Counsel and Chief Compliance Officer | Apr 15, 2025 | |||
| Vijay Kasturi | Chief Medical Officer | Apr 15, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|